Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, today ...

Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

GSK plc (LSE/NYSE: GSK) announced it is investing £50 million into a major new five-year collaboration with the University of ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

GSK has announced a £50m ($54.3m) investment in a partnership with the University of Cambridge to expedite R&D in ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

Earnings before interest, tax, depreciation, and amortisation (Ebitda) is likely to remain flat at Rs 3,698.7 crore on an ...

Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...